This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mazumdar, A. Articles by Kumar, R. Search for Related Content PubMed PubMed Citation Articles by Mazumdar, A. Articles by Kumar, R.

Heregulin Regulation of Urokinase Plasminogen Activator and its Receptor: Human Breast Epithelial Cell Invasion¹

The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Heregulin-ß1, which binds human epidermal growth factor receptors 3 and 4, promotes motility and invasiveness of breast cancer cells. Considering the established role of urokinase plasminogen activator (uPA) and its receptor (uPAR) in invasion, this study was undertaken to explore the role of heregulin-ß1 in regulating uPA and uPAR in breast cancer invasion. The stimulation by heregulin-ß1 of noninvasive human breast cancer MCF-7 cells induced the expression of uPA mRNA, protein, and its plasminogenic activity. This uPA mRNA expression was blocked by a transcriptional inhibitor, actinomycin D, and does require de novo protein synthesis for its optimal induction in MCF-7 cells, but not in mouse mammary epithelial HC11 cells. Heregulin-ß1 also induced the expression of uPAR mRNA and protein in an actinomycin D-sensitive manner and cycloheximide superinduced the uPAR mRNA. Heregulin-ß1-stimulated signaling initiated the transcription from uPA- and uPAR-promoters. These results suggest that heregulin-ß1 regulation of breast cancer cell invasion may be mediated in part through the up-regulation of uPA and uPAR.

This article has been cited by other articles:

				M. Casimiro, O. Rodriguez, L. Pootrakul, M. Aventian, N. Lushina, C. Cromelin, G. Ferzli, K. Johnson, S. Fricke, F. Diba, et al. ErbB-2 Induces the Cyclin D1 Gene in Prostate Epithelial Cells In vitro and In vivo Cancer Res., May 1, 2007; 67(9): 4364 - 4372. [Abstract] [Full Text] [PDF]

				P. Urban, V. Vuaroqueaux, M. Labuhn, M. Delorenzi, P. Wirapati, E. Wight, H.-J. Senn, C. Benz, U. Eppenberger, and S. Eppenberger-Castori Increased Expression of Urokinase-Type Plasminogen Activator mRNA Determines Adverse Prognosis in ErbB2-Positive Primary Breast Cancer J. Clin. Oncol., September 10, 2006; 24(26): 4245 - 4253. [Abstract] [Full Text] [PDF]

				H. Li, X. Ye, C. Mahanivong, D. Bian, J. Chun, and S. Huang Signaling Mechanisms Responsible for Lysophosphatidic Acid-induced Urokinase Plasminogen Activator Expression in Ovarian Cancer Cells J. Biol. Chem., March 18, 2005; 280(11): 10564 - 10571. [Abstract] [Full Text] [PDF]

				P. A. Ritch, S. L. Carroll, and H. Sontheimer Neuregulin-1 Enhances Motility and Migration of Human Astrocytic Glioma Cells J. Biol. Chem., May 30, 2003; 278(23): 20971 - 20978. [Abstract] [Full Text] [PDF]

				P.-W. Tsai, S.-G. Shiah, M.-T. Lin, C.-W. Wu, and M.-L. Kuo Up-regulation of Vascular Endothelial Growth Factor C in Breast Cancer Cells by Heregulin-beta 1. A CRITICAL ROLE OF p38/NUCLEAR FACTOR-kappa B SIGNALING PATHWAY J. Biol. Chem., February 14, 2003; 278(8): 5750 - 5759. [Abstract] [Full Text] [PDF]

				L. Adam, A. Mazumdar, T. Sharma, T. R. Jones, and R. Kumar A Three-Dimensional and Temporo-Spatial Model to Study Invasiveness of Cancer Cells by Heregulin and Prostaglandin E2 Cancer Res., January 1, 2001; 61(1): 81 - 87. [Abstract] [Full Text]